Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis
- 12 January 2021
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 131 (7), E2125-E2130
- https://doi.org/10.1002/lary.29385
Abstract
Objective/Hypothesis Glutamine inhibition has been demonstrated an antifibrotic effect in iatrogenic laryngotracheal stenosis (iLTS) scar fibroblasts in vitro. We hypothesize that broadly active glutamine antagonist, DON will reduce collagen formation and fibrosis‐associated gene expression in iLTS mice. Study Design Prospective controlled animal study. Methods iLTS in mice were induced by chemomechanical injury of the trachea using a bleomycin‐coated wire brush. PBS or DON (1.3 mg/kg) were administered by intraperitoneal injection (i.p.) every other day. Laryngotracheal complexes were harvested at days 7 and 14 after the initiation of DON treatment for the measurement of lamina propria thickness, trichrome stain, immunofluorescence staining of collagen 1, and fibrosis‐associated gene expression. Results The study demonstrated that DON treatment reduced lamina propria thickness (P = .025) and collagen formation in trichrome stain and immunofluorescence staining of collagen 1. In addition, DON decreased fibrosis‐associated gene expression in iLTS mice. At day 7, DON inhibited Col1a1 (P < .0001), Col3a1 (P = .0046), Col5a1 (P < .0001), and Tgfβ (P = .023) expression. At day 14, DON reduced Co1a1 (P = .0076) and Tgfβ (P = .023) expression. Conclusions Broadly active glutamine antagonist, DON, significantly reduces fibrosis in iLTS mice. These results suggest that the concept of glutamine inhibition may be a therapeutic option to reduce fibrosis in the laryngotracheal stenosis. Level of Evidence N/A Laryngoscope, 2021Keywords
Funding Information
- National Institute on Deafness and Other Communication Disorders (1K23DC014082, 1R01DC018567, R21DC017225)
This publication has 33 references indexed in Scilit:
- Dysregulated Macrophages Are Present in Bleomycin‐Induced Murine Laryngotracheal StenosisOtolaryngology -- Head and Neck Surgery, 2015
- Causes and consequences of adult laryngotracheal stenosisThe Laryngoscope, 2014
- An In Situ, In Vivo Murine Model for the Study of Laryngotracheal StenosisJAMA Otolaryngology–Head & Neck Surgery, 2014
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast CancerMolecular Cancer Therapeutics, 2014
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Prognostic factors in laryngotracheal injury following intubation and/or tracheotomy in ICU patientsEuropean Archives of Oto-Rhino-Laryngology, 2005
- Pathophysiology of Subglottic Tracheal Stenosis in ChildhoodProgress in Pediatric Surgery, 1987
- Risk Factors for Neonatal Acquired Subglottic StenosisAnnals of Otology, Rhinology & Laryngology, 1986
- Phase II evaluation of DON (6-Diazo-5-Oxo-L-Norleucine) in patients with advanced colorectal carcinomaAmerican Journal of Clinical Oncology, 1982
- [45] Glutamine binding sitesMethods in Enzymology, 1977